本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Centessa Pharmaceuticals plc

28.70
-0.7000-2.38%
盤後28.00-0.7000-2.44%19:39 EDT
成交量:138.56萬
成交額:4,042.64萬
市值:41.90億
市盈率:-15.76
高:29.93
開:29.35
低:28.68
收:29.40
52周最高:30.58
52周最低:9.60
股本:1.46億
流通股本:9,712.58萬
量比:0.82
換手率:1.43%
股息:- -
股息率:- -
每股收益(TTM):-1.8212
每股收益(LYR):-2.0595
淨資產收益率:-60.62%
總資產收益率:-25.26%
市淨率:13.89
市盈率(LYR):-13.94

資料載入中...

2026/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

重要事件披露

Form 8-K - Current report
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]